Literature DB >> 9742400

Generation of purified neural precursors from embryonic stem cells by lineage selection.

M Li1, L Pevny, R Lovell-Badge, A Smith.   

Abstract

Mouse embryonic stem (ES) cells are non-transformed cell lines derived directly from the pluripotent founder tissue in the mouse embryo, the epiblast [1-3]. Aggregation of ES cells triggers the generation of a diverse array of cell types, including neuronal cells [4-7]. This capacity for multilineage differentiation is retained during genetic manipulation and clonal expansion [8]. In principle, therefore, ES cells provide an attractive system for the molecular and genetic dissection of developmental pathways in vitro. They are also a potential source of cells for transplantation studies. These prospects have been frustrated, however, by the disorganised and heterogeneous nature of development in culture. We have therefore developed a strategy for genetic selection of lineage-restricted precursors from differentiating populations. Here, we report that application of such lineage selection enables efficient purification of neuroepithelial progenitor cells that subsequently differentiate efficiently into neuronal networks in the absence of other cell types.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742400     DOI: 10.1016/s0960-9822(98)70399-9

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  78 in total

Review 1.  The nature and composition of the internal environment of the developing brain.

Authors:  K M Dziegielewska; G W Knott; N R Saunders
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

2.  Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells.

Authors:  M Schuldiner; O Yanuka; J Itskovitz-Eldor; D A Melton; N Benvenisty
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  Genetic and functional differences between multipotent neural and pluripotent embryonic stem cells.

Authors:  Kevin A D'Amour; Fred H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-15       Impact factor: 11.205

4.  The Sox-2 regulatory regions display their activities in two distinct types of multipotent stem cells.

Authors:  Satoru Miyagi; Tetsuichiro Saito; Ken-ichi Mizutani; Norihisa Masuyama; Yukiko Gotoh; Atsushi Iwama; Hiromitsu Nakauchi; Shinji Masui; Hitoshi Niwa; Masazumi Nishimoto; Masami Muramatsu; Akihiko Okuda
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

5.  Generation of highly enriched V2a interneurons from mouse embryonic stem cells.

Authors:  Nisha R Iyer; James E Huettner; Jessica C Butts; Chelsea R Brown; Shelly E Sakiyama-Elbert
Journal:  Exp Neurol       Date:  2016-01-16       Impact factor: 5.330

6.  Chromatin remodeling and histone modification in the conversion of oligodendrocyte precursors to neural stem cells.

Authors:  Toru Kondo; Martin Raff
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

Review 7.  Midbrain dopaminergic development in vivo and in vitro from embryonic stem cells.

Authors:  Sarah L Maxwell; Meng Li
Journal:  J Anat       Date:  2005-09       Impact factor: 2.610

Review 8.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

9.  The use of gating technology in bioengineering insulin-secreting cells from embryonic stem cells.

Authors:  Enrique Roche; Mark M Burcin; Sybille Esser; Manfred Rüdiger; Bernat Soria
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

10.  H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment.

Authors:  Menno P Creyghton; Styliani Markoulaki; Stuart S Levine; Jacob Hanna; Michael A Lodato; Ky Sha; Richard A Young; Rudolf Jaenisch; Laurie A Boyer
Journal:  Cell       Date:  2008-11-06       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.